Page last updated: 2024-08-22

cladribine and losartan potassium

cladribine has been researched along with losartan potassium in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	2 (66.67)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (33.33)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ	1
Couban, S; Wilson, WE	1
Reilly, JT	1

Reviews

1 review(s) available for cladribine and losartan potassium

Article	Year
Pathogenesis and management of idiopathic myelofibrosis. Bailliere's clinical haematology, 1998, Volume: 11, Issue:4 Topics: Anemia; Animals; Bone Marrow; Bone Marrow Transplantation; Cladribine; Combined Modality Therapy; Disease Models, Animal; Erythropoietin; Growth Substances; Hematopoietic Stem Cells; Humans; Hydroxyurea; Interferon-alpha; Karyotyping; Megakaryocytes; Mice; Polyethylene Glycols; Primary Myelofibrosis; Prognosis; Recombinant Proteins; Splenectomy; Stromal Cells; Thrombopoietin; Vitamin D	1998

Article

Year

Pathogenesis and management of idiopathic myelofibrosis.

Bailliere's clinical haematology, 1998, Volume: 11, Issue:4

Topics: Anemia; Animals; Bone Marrow; Bone Marrow Transplantation; Cladribine; Combined Modality Therapy; Disease Models, Animal; Erythropoietin; Growth Substances; Hematopoietic Stem Cells; Humans; Hydroxyurea; Interferon-alpha; Karyotyping; Megakaryocytes; Mice; Polyethylene Glycols; Primary Myelofibrosis; Prognosis; Recombinant Proteins; Splenectomy; Stromal Cells; Thrombopoietin; Vitamin D

1998

Other Studies

2 other study(ies) available for cladribine and losartan potassium

Article	Year
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development. Toxicological sciences : an official journal of the Society of Toxicology, 2013, Volume: 136, Issue:1 Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests	2013
Use of 2-chlorodeoxyadenosine, granulocyte-colony-stimulating factor, and erythropoietin in a Jehovah's Witness with hairy cell leukemia. American journal of hematology, 1995, Volume: 49, Issue:3 Topics: Anemia; Cladribine; Drug Therapy, Combination; Erythropoietin; Female; Granulocyte Colony-Stimulating Factor; Humans; Leukemia, Hairy Cell; Middle Aged; Recombinant Proteins; Religion	1995

Article

Year

A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.

Toxicological sciences : an official journal of the Society of Toxicology, 2013, Volume: 136, Issue:1

Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests

2013

Use of 2-chlorodeoxyadenosine, granulocyte-colony-stimulating factor, and erythropoietin in a Jehovah's Witness with hairy cell leukemia.

American journal of hematology, 1995, Volume: 49, Issue:3

Topics: Anemia; Cladribine; Drug Therapy, Combination; Erythropoietin; Female; Granulocyte Colony-Stimulating Factor; Humans; Leukemia, Hairy Cell; Middle Aged; Recombinant Proteins; Religion

1995